For help on how to get the results you want, see our search tips.
157 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Categories
Human Remove Human filter
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Exceptional circumstances Remove Exceptional circumstances filter
Orphan medicine Remove Orphan medicine filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
Date of authorisation: 08/05/2017,
, 
, 
, Revision: 7, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
Date of authorisation: 08/09/2015,, , , Revision: 5, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Myozyme (updated)
Date of authorisation: 28/03/2006,, Revision: 16, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Foclivia (updated)
Date of authorisation: 18/10/2009,, Revision: 9, Authorised, Last updated: 04/12/2019
-
List item
Human medicine European public assessment report (EPAR): Mepsevii (updated)
Date of authorisation: 23/08/2018,, , , Revision: 3, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Xermelo (updated)
Date of authorisation: 17/09/2017,, , Revision: 8, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq (updated)
Date of authorisation: 28/08/2015,, , , Revision: 10, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Farydak (updated)
Date of authorisation: 28/08/2015,, , Revision: 7, Authorised, Last updated: 02/12/2019
-
List item
Human medicine European public assessment report (EPAR): Translarna (updated)
Date of authorisation: 31/07/2014,, , 
, Revision: 13, Authorised, Last updated: 02/12/2019
-
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
Date of authorisation: 16/11/2011,, , , Revision: 15, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Somavert (updated)
Date of authorisation: 12/11/2002,, Revision: 21, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Crysvita (updated)
Date of authorisation: 19/02/2018,, , , Revision: 2, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Atriance (updated)
Date of authorisation: 22/08/2007,, , , Revision: 21, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Elaprase (updated)
Date of authorisation: 08/01/2007,, , , Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Revatio (updated)
Date of authorisation: 28/10/2005,, Revision: 38, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, , , Revision: 5, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Trisenox (updated)
Date of authorisation: 05/03/2002,, Revision: 27, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Exjade (updated)
Date of authorisation: 28/08/2006,, , Revision: 43, Authorised, Last updated: 25/11/2019
-
List item
Human medicine European public assessment report (EPAR): Besponsa (updated)
Date of authorisation: 28/06/2017,, , Revision: 5, Authorised, Last updated: 25/11/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
Date of authorisation: 18/10/2013,, , , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
Date of authorisation: 14/10/2016,, Revision: 4, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Nexavar (updated)
Date of authorisation: 19/07/2006,, Revision: 28, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos) (updated)
Date of authorisation: 23/08/2018,, Revision: 2, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Esbriet
Date of authorisation: 27/02/2011,, Revision: 24, Authorised, Last updated: 15/11/2019
-
List item
Human medicine European public assessment report (EPAR): Lenvima
Date of authorisation: 28/05/2015,, 
, Revision: 10, Authorised, Last updated: 15/11/2019